Bruce Charles Farrenkopf

Title: Bruce Charles Farrenkopf: Innovator in Biochemical Solutions

Introduction

Bruce Charles Farrenkopf is a notable inventor based in Clifton, NJ (US). He has made significant contributions to the field of biochemistry, particularly in the development of methods and kits for determining digoxin levels and stabilizing angiotensin I solutions. With a total of 2 patents, his work has had a meaningful impact on medical diagnostics.

Latest Patents

Farrenkopf's latest patents include a method and kit for determining total digoxin levels. This innovative method involves disrupting the digoxin-protein complex in biological fluid samples using a dissociation agent. The process allows for the selective passage of digoxin-containing solutions through a centrifugal ultrafilter, facilitating accurate measurement through fluorescence polarization assays. Additionally, he has developed stabilized angiotensin I solutions that resist enzymatic degradation, enhancing the reliability of immunoassay kits for plasma renin level determination.

Career Highlights

Bruce Charles Farrenkopf is currently associated with Hoffmann-La Roche Inc., where he continues to advance his research and development efforts. His work has been instrumental in improving diagnostic methods that are crucial for patient care.

Collaborations

Farrenkopf has collaborated with notable colleagues, including Magdalena U Gomez and Richard A Kaufman. These partnerships have contributed to the successful development of his patented technologies.

Conclusion

In summary, Bruce Charles Farrenkopf is a distinguished inventor whose work in biochemical solutions has paved the way for advancements in medical diagnostics. His innovative methods and collaborations reflect his commitment to improving healthcare outcomes.